P42 Nurse-led safe switching from original reference product infliximab to a biosimilar in patients with juvenile idiopathic arthritis and uveitis: a single centre experience where baseline and post-switch infliximab levels and antibodies were obtained
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.